NYSE · CIK 0001100682 · SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
CRL chart by TradingView
PRICE HISTORY
LIVE · NYSECRL chart by TradingView
- REVENUE FY2025 ENDED DEC 2025
- $4.0B
- EBITDA
- $0.4B
- FREE CASH FLOW
- $0.5B
- EPS
- $-2.91
- GROSS MARGIN
- —
- ROIC
- -4.89%
Q2 FY26ENDED JUN 2026HOVERDRAG ACROSS ANY CHART TO SCRUB ALL 24 · 40 QUARTERS SHOWNVALUATIONGROWTHPROFITABILITY & RETURNSCASH & CAPITALBALANCE SHEET
VALUATION
what you pay for a unit of the business7 CHARTS⤢
P / E RATIO (TTM)
—
+1445%20.9x432.5x
⤢
P / SALES (TTM)
2.6x
+2%1.8x6.9x
⤢
P / BOOK
3.6x
-20%2.2x9.7x
⤢
EV / EBITDA (TTM)
26.2x
+73%10.2x29.1x
⤢
EV / REVENUE (TTM)
2.5x
-22%1.8x6.8x
⤢
FCF YIELD (TTM)
3.58%
-3.0pp1.91%7.82%
⤢
DIVIDEND YIELD (TTM)
—
GROWTH
is the business getting bigger5 CHARTS⤢
REVENUE
$1.0B
+136%⤢
EBITDA (DERIVED)
$0.2B
+101%⤢
NET INCOME
$-0.0B
-104%⤢
EPS (DILUTED)
$-0.03
-104%⤢
REVENUE GROWTH YOY
-2.72%
-24.5pp-7.85%33.99%
PROFITABILITY & RETURNS
what survives to the bottom, and what it earns on capital4 CHARTS⤢
FCF MARGIN
14.80%
+0.1pp-1.49%21.10%
⤢
RETURN ON CAPITAL
-8.99%
-16.1pp-8.99%21.82%
⤢
RETURN ON EQUITY (TTM)
-8.40%
-24.8pp-8.40%19.37%
MARGIN FUNNEL
every line is a share of the same revenue, so they read on one scale — the gaps are what each layer takes out, and net rises above operating when income arrives from outside the businessGROSS MARGIN—
OPERATING MARGIN11.94%
NET MARGIN-0.15%
FCF MARGIN14.80%
CASH & CAPITAL
where the money actually goes5 CHARTS⤢
FREE CASH FLOW
$0.1B
+137%⤢
STOCK-BASED COMP
$0.0B
+87%⤢
CAPITAL EXPENDITURE
$0.0B
+225%⤢
SHARES OUTSTANDING
0.05B
-0%⤢
DIVIDEND / SHARE
—
BALANCE SHEET
how much cushion there is3 CHARTS⤢
CASH & EQUIVALENTS
$0.2B
+82%⤢
TOTAL DEBT
$0.0B
-100%⤢
DEBT / EBITDA (TTM)
0.0x
-100%0.0x4.3x
OWNERSHIP
10 LARGEST HOLDERS · WHO OWNS THE FLOATINSTITUTIONS 124.18%INSIDERS 0.64%OTHER / RETAIL 0.00%784 INSTITUTIONAL FILERS
| HOLDER | % HELD | SHARES | VALUE | CHANGE |
|---|---|---|---|---|
| Blackrock Inc. | 8.08% | 3.9M | $1.03B | +2.8% |
| FMR, LLC | 7.24% | 3.5M | $924.5M | +99.3% |
| Vanguard Capital Management LLC | 6.71% | 3.2M | $856.6M | NEW |
| Invesco Ltd. | 5.02% | 2.4M | $641.2M | -11.1% |
| Vanguard Portfolio Management LLC | 4.81% | 2.3M | $613.8M | NEW |
| Harris Associates L.P. | 4.51% | 2.2M | $576.0M | +28.4% |
| Allspring Global Investments Holdings, LLC | 4.18% | 2.0M | $533.2M | -0.1% |
| State Street Corporation | 3.92% | 1.9M | $501.2M | +0.1% |
| Dimensional Fund Advisors LP | 3.46% | 1.7M | $442.0M | +14.6% |
| Wellington Management Group, LLP | 3.41% | 1.6M | $435.8M | -6.9% |
AS OF 2026-03-31 · MOST RECENT 13F FILINGS
SOURCE → 10-K · 10-Q · 8-K / GUIDANCE · ALL FILINGS
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.